Valuation: Tristel plc

Market Cap 186M 250M 218M 201M 353M 23.8B 359M 2.41B 945M 11.72B 937M 917M 40.31B P/E 2026 *
23.7x
P/E 2027 * 20.5x
Enterprise Value 177M 237M 207M 191M 335M 22.61B 341M 2.29B 898M 11.14B 890M 871M 38.3B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.11x
Free-Float
93.03%
Yield 2026 *
3.84%
Yield 2027 * 4.04%
1 day-4.52%
1 week-4.52%
Current month-4.52%
1 month-4.52%
3 months+5.60%
6 months+2.72%
Current year+2.72%
1 week 5.28
Extreme 5.28
5.28
1 month 5.28
Extreme 5.28
5.28
Current year 5
Extreme 5
6
1 year 5
Extreme 5
6
3 years 5
Extreme 5
6
5 years 5
Extreme 5
6
10 years 5
Extreme 5
6
Manager TitleAgeSince
Chief Executive Officer - 2026-06-29
Director of Finance/CFO - 2024-12-31
Chief Tech/Sci/R&D Officer - 2021-10-31
Director TitleAgeSince
Director/Board Member 54 2017-10-18
Chairman 65 2019-12-16
Director/Board Member 68 2020-04-26
Change 5-day change 1-year change 3-year change Capi.($)
-4.52%-4.52% - - 250M
+0.12%+1.54%-33.19%-50.26% 13.81B
+3.14%+9.42%+71.77%+116.47% 4.39B
-0.81%+1.49%+315.67%+204.68% 3.4B
+0.18%-4.19%-30.67%-34.04% 2.38B
+2.49%+0.92%-43.57%-68.00% 1.89B
+0.31%-3.55%-28.92%-29.73% 1.83B
-0.75%-2.94%-3.65%-23.70% 1.3B
+1.18%+0.59%+28.57%+34.65% 982M
+1.40%+0.23%-18.88%-17.33% 927M
Average +0.27%-0.90%+28.57%+14.75% 3.43B
Weighted average by Cap. +0.60%+0.04%+23.50%+7.62%

Financials

2026 *2027 *
Net sales 51.18M 68.69M 60.08M 55.42M 97.12M 6.55B 98.75M 662M 260M 3.23B 258M 252M 11.09B 56.32M 75.58M 66.11M 60.98M 107M 7.21B 109M 729M 286M 3.55B 284M 278M 12.21B
Net income 7.93M 10.65M 9.31M 8.59M 15.05M 1.02B 15.31M 103M 40.3M 500M 39.97M 39.1M 1.72B 9.19M 12.34M 10.79M 9.95M 17.44M 1.18B 17.74M 119M 46.7M 580M 46.32M 45.31M 1.99B
Net Debt -9.27M -12.44M -10.88M -10.04M -17.59M -1.19B -17.89M -120M -47.09M -585M -46.71M -45.69M -2.01B -10.98M -14.74M -12.89M -11.89M -20.84M -1.41B -21.19M -142M -55.8M -693M -55.34M -54.14M -2.38B
Logo Tristel plc
Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Employees
270
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.875GBP
Average target price
4.748GBP
Spread / Average Target
+22.53%

Annual profits - Rate of surprise